BETA3_LVH-206824 Abstracts presentation at heart failure meetings

Summary

Starting at month 12, abstracts on the scope, design and implementation of the clinical trial are submitted for presentation at Heart Failure congresses

More information & hyperlinks

Web resources:

https://www.ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5ada9f192&appId=PPGMS

Associated projects

BETA3_LVH - A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease

Organisations

Not specified